screening

Assessment of sars-cov-2 infection through rapid serology testing in the homeless population in the city of rome, Italy. Preliminary results

Background: The development of COVID-19 pandemic has affected all segments of the population; however, it had a significant impact on vulnerable subjects, such as in people experiencing homelessness. The aim of this study was to evaluate the prevalence of COVID-19 spread in homeless persons in the city of Rome, Italy. Design and Methods: Patients included in the study underwent a clinical evaluation and rapid antibody analysis on capillary blood for the presence of immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies to SARS-CoV-2 virus.

Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool

Purpose: Since subcutaneous implantable cardioverter defibrillator (S-ICD) introduction, the pre-implant screening based on a dedicated manual ECG tool (MST) was required to assure adequate sensing by the S-ICD. A novel automated screening tool (AST) has been recently developed. We assessed and compared the pass rate with AST and MST, and we measured the agreement between screening tools. Methods: Three electrodes were positioned at locations mimicking the placement of the S-ICD, and ECG recordings were collected in the supine and standing postures at rest.

Advances in thermoanalytical techniques: may aspirin interfere with ß-thalassemia diagnosis?

Thermogravimetry coupled with chemometrics has proved to be a rapid and cost-effective diagnostic tool for β-thalassemia screening. This model, consisting of Partial Least Square-Discriminant Analysis (PLS-DA), permitted the discrimination of thalassemic patients and healthy individuals, using thermogravimetric curves of blood samples. In this study, the impact of aspirin on the capability of the TGA/chemometric validated model to screen for thalassemia was investigated.

MicroNIR/Chemometrics: a new analytical platform for fast and accurate detection of Δ9-Tetrahydrocannabinol (THC) in oral fluids

Background: Δ9-Tetrahydrocannabinol (THC) is already considered one of the most addictive substances since an increasing number of consumers/abusers of THC and THC based products are observed worldwide. In this work, the capabilities of a novel miniaturized and portable MicroNIR spectrometer were investigated in order to propose a practical and intelligible test allowing the rapid and easy screening of Δ9-Tetrahydrocannabinol (THC) oral fluids without any pretreatment.

"Lab-on-Click" detection of illicit drugs in oral fluids by microNIR-chemometrics

A novel, entirely automated MicroNIR-chemometric platform was developed for the "lab-on-click" detection of illicit drugs in nonpretreated oral fluids, and a novel tool for the first-level test is proposed. Calibration of the method was achieved by collecting oral-fluid specimens from volunteers, and chemometric analysis was considered for the development of models for prediction for cocaine, amphetamine, and Δ9-tetrahydrocannabinol.

Update on thalassemia diagnosis: new insights and methods

A novel approach based on Thermogravimetric analysis followed by Chemometrics (TGA/Chemometrics) is provided for Thalassemia diagnosis and a comprehensive study consisting of the coupled approach TGA/Chemometrics, the Complete Blood Count (CBC) and Red Blood Cell (RBC) indices is developed and results are compared. A number of 128 subjects were involved in this study included 16 thalassemia intermedia transfusion-dependent (TI-TD) patients, 18 thalassemia intermedia non transfusion-dependent (TI-NTD) patients, and 14 thalassemia major β (TM-TD) patients.

Miniaturized analytical platform for cocaine detection in oral fluids by MicroNIR/Chemometrics

In the field of forensic toxicology, the use of non-destructive and easy-to-use analytical techniques deserves remarkable attention, especially in those situations involving public health and security. In addition, the miniaturization
and portability of one-touch devices for the detection of specific threats is required more and more.
In this study, a novel on-site MicroNIR/Chemometric platform was developed to perform a real-time prediction
of cocaine and its metabolites in non pre-treated oral fluid.

Sperimentazione preliminare di un test di screening a consistenze multiple per la valutazione della disfagia orofaringea

Introduzione: L’inquadramento in regime di ricovero ospedaliero della gravità della disfagia orofaringea (DO) mediante test di screening migliora la gestione del paziente, stabilendo precocemente il corretto approccio dietetico e prevenendo complicanze respiratorie. Sono stati proposti numerosi test basati sulla evocazione del riflesso della tosse all’ assunzione di acqua, con una specificità del 50–88% ed una sensibilità del 27–85%.

Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy

Background: Health workers (HWs) are at high risk of acquiring SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infections. Therefore, health authorities further recommend screening strategies for SARS-CoV-2 infection in exposed or high-risk HWs. Nevertheless, to date, the best/optimal method to screen HWs for SARS-CoV-2 infection is still under debate, and data on the prevalence of SARS-CoV-2 infection in HWs are still scarce.

Knowledge, experiences, and attitudes toward Mantoux test among medical and health professional students in Italy. a cross-sectional study

Introduzione. Il piano d'azione dell'Organizzazione Mondiale della Sanità per l'eliminazione della tubercolosi nei Paesi con bassa incidenza di tubercolosi prevede lo screening per la tubercolosi attiva e latente in determinati gruppi ad alto rischio, inclusi gli operatori sanitari. In questo contesto, gli studenti di medicina e professioni sanitarie, esposti alla trasmissione nosocomiale di tubercolosi durante l'attività formativa e di tirocinio, rappresentano la popolazione target per lo screening della tubercolosi.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma